Year: 2013
Type: article
Abstract: biobank total twelve million dollars, representing a several-fold return on investment. Conclusions: The seamless integration of the automated MyCode process with existing clinical infrastructure maximizes the efficiency of research sample collection and minimizes costs. The process allows resources to be focused on interaction with the patients during consent. The opt-in consent allows samples to be linked to EMR data. The persistent link allows repeat access to the patient's EMR data for longitudinal studies. This approach is highly efficient and does not require patients to have an extra needle stick or research visit, which contributes to the high enrollment rate. The trade-off is a potential lag between consent and sample collection. Future goals include improvements in enrollment efficiency and developing approaches for returning results.
Source: Clinical Medicine & Research
Institution: Geisinger Health System
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2125702963